Reduced Relapse Incidence with FLAMSA–RIC Compared with Busulfan/Fludarabine for Acute Myelogenous Leukemia Patients in First or Second Complete Remission: A Study from the Acute Leukemia Working Party of the European Society for Blood and Marrow Transplantation
2018 ◽
Vol 24
(11)
◽
pp. 2224-2232
◽
2019 ◽
Vol 25
(10)
◽
pp. 1975-1983
◽
2021 ◽
Vol 27
(3)
◽
pp. S136-S137
2013 ◽
Vol 19
(7)
◽
pp. 1102-1108
◽
2018 ◽
Vol 53
(6)
◽
pp. 683-691
◽
2019 ◽
Vol 25
(3)
◽
pp. S48-S49
◽